• Contact: +91-9643310025, 9643312749
  • Generic selectors
    Exact matches only
    Search in title
    Search in content
    Search in posts
    Search in pages
    Filter by Categories
    Annual brand plans
    Autoimmune diseases
    Blog
    Conference support
    Corporate strategy and R & D consulting
    KOL support
    Medical
    MSL training
    Orphan Diseases
    Pre-& post launch activities
    Sales & marketing
    Sales force training
Pharmintel

Blog

On Nov 25, the U.S. Food and Drug Administration granted accelerated approval to Oxbryta (voxelotor) for the treatment of sickle cell disease (SCD) in adults and pediatric patients 12 years of age and older. Unmet Medical Need ParametersUnmet Medical Need in sickle cell disease after SIKLOSUnmet Medical Need in sickle cell disease after OXBRYTA Treatment Adequacy Current treatment increases hemoglobin F levels in red blood cells (RBCs), decreasing neutrophils, increasing the water content of RBCs,
On May 15, the U.S. Food and Drug Administration approved Adakveo (crizanlizumab-tmca), a treatment to reduce the frequency of vaso-occlusive crisis – a common and painful complication of sickle cell disease that occurs when blood circulation is obstructed by sickled red blood cells – for patients age 16 years and older. Unmet Medical Need ParametersCurrent Unmet Medical Need in vaso-occlusive crisis in sickle cell diseaseUnmet Medical Need after Adakveo (crizanlizumab-tmca) Low to moderate unmet medical
Well, it is not an easy task and we need to analyze several points before we start the study. Our market research should be focused on the following parameters: Disease landscapeCompetitive landscapeRegulatory framework In this article, we will cover all the points which should be considered while doing market research. To understand the disease landscape, we need to study the following sub-parameters: Epidemiology which will include the disease incidence and prevalenceUnmet needs in the marketDrivers

CRM SEGMENTATION: How do pharma companies do it?

Posted by pharmintel on October 17, 2019

0
Category: Blog
Sales territory design and management is a very sophisticated and complicated process in pharma industry. It’s definitely a win-win situation for the pharma company if the sales force is aligned properly and helps in increasing their revenue. The sales representatives are also motivated to achieve target and find innovative ways to improve the sales. Have you ever thought how to properly design the territories? Major factors are workload and change in opportunities like market shift

Turn your Key Opinion Leader into an Influencer

Posted by pharmintel on October 13, 2019

0
Category: Blog
Pharma companies often spent time & resources running after the KOL’s. A KOL can also be an influencer who will play a major role for the pharma industry. A KOL is not only an expert whose opinion is valued in a specific industry but also listened by a broader audience. Pharma companies identify relevant KOLs across multiple therapy areas of expertise and maintain a high-quality network of thought leaders from across the globe. The approach
Contact
+91 9643310025, 9643312749
© 2019 Pharmintel